rs55980069

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005592.4(MUSK):​c.398T>C​(p.Ile133Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00592 in 1,539,768 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I133V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 38 hom. )

Consequence

MUSK
NM_005592.4 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.74

Publications

5 publications found
Variant links:
Genes affected
MUSK (HGNC:7525): (muscle associated receptor tyrosine kinase) This gene encodes a muscle-specific tyrosine kinase receptor. The encoded protein may play a role in clustering of the acetylcholine receptor in the postsynaptic neuromuscular junction. Mutations in this gene have been associated with congenital myasthenic syndrome. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
MUSK Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 9
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006833166).
BP6
Variant 9-110695442-T-C is Benign according to our data. Variant chr9-110695442-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 197256.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00393 (599/152300) while in subpopulation NFE AF = 0.0061 (415/68006). AF 95% confidence interval is 0.00562. There are 0 homozygotes in GnomAd4. There are 298 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 38 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUSKNM_005592.4 linkc.398T>C p.Ile133Thr missense_variant Exon 4 of 15 ENST00000374448.9 NP_005583.1 O15146-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUSKENST00000374448.9 linkc.398T>C p.Ile133Thr missense_variant Exon 4 of 15 5 NM_005592.4 ENSP00000363571.4 O15146-1
MUSKENST00000416899.7 linkc.398T>C p.Ile133Thr missense_variant Exon 4 of 14 5 ENSP00000393608.3 A0A087WSY1
MUSKENST00000189978.10 linkc.398T>C p.Ile133Thr missense_variant Exon 4 of 14 5 ENSP00000189978.6 O15146-2
MUSKENST00000374439.1 linkc.92T>C p.Ile31Thr missense_variant Exon 2 of 4 5 ENSP00000363562.2 F6XAJ2

Frequencies

GnomAD3 genomes
AF:
0.00394
AC:
599
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.0112
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00610
Gnomad OTH
AF:
0.00764
GnomAD2 exomes
AF:
0.00451
AC:
796
AN:
176308
AF XY:
0.00443
show subpopulations
Gnomad AFR exome
AF:
0.00132
Gnomad AMR exome
AF:
0.00260
Gnomad ASJ exome
AF:
0.0109
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00209
Gnomad NFE exome
AF:
0.00673
Gnomad OTH exome
AF:
0.00553
GnomAD4 exome
AF:
0.00613
AC:
8511
AN:
1387468
Hom.:
38
Cov.:
27
AF XY:
0.00600
AC XY:
4122
AN XY:
686668
show subpopulations
African (AFR)
AF:
0.00104
AC:
33
AN:
31828
American (AMR)
AF:
0.00321
AC:
119
AN:
37026
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
276
AN:
25128
East Asian (EAS)
AF:
0.0000267
AC:
1
AN:
37424
South Asian (SAS)
AF:
0.00299
AC:
232
AN:
77716
European-Finnish (FIN)
AF:
0.00207
AC:
105
AN:
50622
Middle Eastern (MID)
AF:
0.00388
AC:
22
AN:
5666
European-Non Finnish (NFE)
AF:
0.00694
AC:
7389
AN:
1064228
Other (OTH)
AF:
0.00578
AC:
334
AN:
57830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
397
793
1190
1586
1983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00393
AC:
599
AN:
152300
Hom.:
0
Cov.:
32
AF XY:
0.00400
AC XY:
298
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41578
American (AMR)
AF:
0.00268
AC:
41
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0112
AC:
39
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00269
AC:
13
AN:
4828
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00610
AC:
415
AN:
68006
Other (OTH)
AF:
0.00756
AC:
16
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
30
60
90
120
150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00559
Hom.:
15
Bravo
AF:
0.00403
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.00110
AC:
4
ESP6500EA
AF:
0.00690
AC:
56
ExAC
AF:
0.00323
AC:
384
Asia WGS
AF:
0.00115
AC:
5
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 05, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 13, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MUSK: BS2 -

not specified Benign:2
Dec 17, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

MUSK-related disorder Benign:1
Jun 29, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 9 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
20
DANN
Benign
0.91
DEOGEN2
Benign
0.13
T;.;.;.;.
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.40
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.86
D;D;D;D;D
MetaRNN
Benign
0.0068
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.53
N;.;N;.;.
PhyloP100
2.7
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.0
N;N;N;.;.
REVEL
Benign
0.042
Sift
Benign
0.061
T;T;T;.;.
Sift4G
Benign
0.62
T;T;T;T;T
Polyphen
0.0060
B;.;.;.;.
Vest4
0.35
MVP
0.36
MPC
0.21
ClinPred
0.019
T
GERP RS
1.2
Varity_R
0.071
gMVP
0.67
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55980069; hg19: chr9-113457722; API